This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: University of Pittsburgh, Id4pharma, LLC. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2023
Title: The Innovative Contributions of Xiang-Qun Xie
Introduction
Xiang-Qun Xie is a prominent inventor based in Sewickley, PA (US). He has made significant contributions to the field of chemical inhibitors and pain management through his innovative research and development. With a total of 8 patents to his name, Xie's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents is the P62-ZZ chemical inhibitor, which presents a method for treating p62-mediated diseases, such as multiple myeloma. This method involves administering a therapeutically effective amount of at least one p62-ZZ inhibitor compound to the subject. Another notable patent is related to hTRPV1 chemical agents, where he discloses novel diphenylurea and benzylbenzenesulfonamide compounds. These compounds are designed to inhibit the activity of TRPV1 and provide methods for treating pain associated with transient receptor potential vanilloid type 1 (TRPV1).
Career Highlights
Xiang-Qun Xie has worked with esteemed organizations, including the University of Pittsburgh and Id4pharma, LLC. His experience in these institutions has allowed him to further his research and contribute to advancements in medical science.
Collaborations
Xie has collaborated with notable colleagues, including Peng Yang and Rentian Feng. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Xiang-Qun Xie's contributions to the field of chemical inhibitors and pain management exemplify the impact of innovative research on medical treatments. His patents and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile